JUPITER NEUROSCIENCES, INC. (JUNS): Nasdaq/NYSE listing notice — Jupiter Neurosciences receives Nasdaq deficiency notices for bid price and market value

JUPITER NEUROSCIENCES, INC.

Two Nasdaq deficiency notices received Feb 26, 2026: bid price <$1.00 for 30 consecutive days.
Market value of listed securities (MVLS) <$35M for 30 consecutive days; both have 180-day cure period to Aug 25, 2026.
To regain bid price compliance, stock must close ≥$1.00 for 10+ consecutive business days.
Company may consider reverse stock split; trading unaffected for now under ticker JUNS.
Failure to cure may lead to delisting; Company can appeal to a hearings panel.

item 3.01 item 7.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

JUPITER NEUROSCIENCES, INC. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2)

Exact text from the filing

February 26, 2026, Jupiter Neurosciences, Inc. (the “ Company ”) received two written notices (each, a “ Notice ” and together, the “ Notices ”) from the Listing Qualifications Department of Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that (i) the listing of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”) was not in compliance with the minimum bid price requirement (the “ Minimum Bid Price Requirement ”) as set forth under Nasdaq Listing Rule 5550(a)(2) for continued listing of its Common Stock on The Nasdaq Capital Market, as the closing bid price

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

JUPITER NEUROSCIENCES, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

February 26, 2026, Jupiter Neurosciences, Inc. (the “ Company ”) received two written notices (each, a “ Notice ” and together, the “ Notices ”) from the Listing Qualifications Department of Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that (i) the listing of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”) was not in compliance with the minimum bid price requirement (the “ Minimum Bid Price Requirement ”) as set forth under Nasdaq Listing Rule 5550(a)(2) for continued listing of its Common Stock on The Nasdaq Capital Market, as the closing bid price

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

JUPITER NEUROSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0001493152-26-008344

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.